纵横研报
Tag

#Testing Inspection Certification

03Reports
·检测与认证服务 ·In-house Research

ALS Limited: A High-Quality Compounder with a Cyclical Sidecar

ALS Limited is a global laboratory-testing group that earns most of its revenue from Life Sciences yet a disproportionate share of margin from minerals-related Commodities testing, so a diversified TIC provider still trades, at key moments, like a high-quality miner's service proxy. FY26 delivered record revenue of A$3.32 billion and an 18.0% underlying EBIT margin, hitting the FY27 strategic targets a year early, but at A$23.36 the stock trades near 37 times trailing EPS with the margin of safety put at zero. Rating Hold: a strong dual-engine testing franchise whose price already discounts commodities strength, acquisition repair and future hub productivity, leaving little room for disappointment.

ALQ.AU ALS Limited #Testing Inspection Certification#Life Sciences#Minerals#Compounder#Australia#Valuation
Hold
·检测与认证服务 ·In-house Research

SGS: High-Quality TIC Compounder at Full Value

SGS SA is the world's broadest publicly listed testing, inspection and certification group, monetizing accreditation, network density and a century-old reputation for independence across more than 2,500 facilities in 115 countries. In 2025 it generated CHF 6.945 billion of sales at a 16.0% adjusted operating margin and converted profit to cash at roughly 1.9x net income, yet at about 25.9x trailing earnings and a 3.6% dividend yield the market already prices the Strategy 27 reacceleration, leaving no conservative margin of safety against a CHF 80-84 fair value. Rating Hold: a high-quality TIC compounder whose current price captures most of the Strategy 27 improvement and leaves limited conservative upside.

SGSN.SW SGS SA #TIC#Testing Inspection Certification#Quality Assurance#Compounding#Switzerland
Hold
·检测与认证服务 ·In-house Research

Bureau Veritas: Quality TIC, Priced for Reacceleration

Bureau Veritas is an 1828-founded global testing, inspection and certification network operating across six lines that sells institutional trust, with 2025 revenue of EUR 6.47 billion, a 16.3% adjusted operating margin, and EUR 824 million of free cash flow. The real question is durability rather than quality: after a strong 2024 of 10.2% organic growth, Q1 2026 organic growth slowed to 4.5% and management trimmed full-year guidance on Government Services contract exits, leaving the stock at about 18.4x 2025 adjusted EPS of EUR 1.42 with a conservative fair value near EUR 23 already below the current EUR 26.16 price. Rating Hold: Bureau Veritas remains a strong TIC franchise, but the current price already discounts much of the LEAP 28 plan before 2026 re-acceleration is proven.

BVI.PA Bureau Veritas SA #TIC#Testing Inspection Certification#Quality Assurance#Compounding
Hold